High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin Lymphoma

Overview of attention for article published in BMC Cancer, January 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (58th percentile)

Mentioned by

twitter: 2 X users

Readers on

mendeley: 15 Mendeley

Summary X

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 4,931 followers.

RT @Lymphoma_Papers: High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin Lymp…

04 Jan 2022

Reply Repost Favourite

High efficacy of PD-1 inhibitor after initial failure of PD-L1 inhibitor in Relapsed/Refractory classical Hodgkin Lymphoma #lymphoma #lymsm https://t.co/OtsRkYJHal

04 Jan 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.